This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Among the firms covered by BioCommerce Week there were 16 mergers or acquisitions signed or completed for a total of at least $15.15 billion during the first half of 2007 (see table below). More than half of that total dollar amount comes from General Electric’s agreement to buy Abbott’s diagnostics business for $8.13 billion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.